Clinical Trial Update: Evaluation of the NantHealth GPS Cancer Test in Patients With Advanced Cancers

View source ↗

Summary

This clinical trial update notes the termination of the study evaluating the NantHealth GPS Cancer Test in patients with advanced cancers. The listed conditions…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Colon Cancer
• Lung Cancer
• Melanoma
• Pancreatic Cancer
• Prostate Cancer

Snippet

Sponsor: Cota Inc. | Conditions: Pancreatic Cancer, Metastatic Breast Cancer | Status: TERMINATED